Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Other News Releases in Biotechnology

DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion

QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission

Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland

Other News Releases in Corporate Expansion

DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion

Catherines Plus Sizes Expands to Include 33 Outlet Locations

Shot Spirits Corporation Announces Revenue Opportunity Through Georgia Distribution of the ShotPak(R)

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

See more news releases in: Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Corporate Expansion

 

Particle Sciences Acquires Additional Space for Operations

BETHLEHEM, Pa., Nov. 10 /PRNewswire/ -- Particle Sciences Inc., a leading pharmaceutical CRO, has further expanded their capabilities by the acquisition of additional space bringing their total to approximately 21,000 sq ft. "Our current workload and existing pipeline simply necessitates this addition," says Dr. Mark Mitchnick, CEO. "2009 has been a record year for us and we have pretty good visibility on the next 12 months. The additional space will be used to expand our cGMP warehouse capacity. Also, we will construct a purpose-built sampling and weighing area for highly potent materials," says Mitchnick. According to Robert Lee, PhD, Particle Sciences VP of Pharmaceutical Development, "Increasingly, clients are coming to us for clinical trial material manufacturing and to work with a greater number of highly potent compounds. We are fortunate that we are able to expand into both of those needs." Particle Sciences expects the new space to be operational in Q1 2010.

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit http://www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861-4701 for information.

    Contact:
    Maureen Cochran
    mcochran@particlesciences.com
    (610) 861-4701

SOURCE Particle Sciences, Inc.

RELATED LINKS
http://www.particlesciences.com